NO20043354L - Terapeutiske akridon- og akridinforbindelser - Google Patents
Terapeutiske akridon- og akridinforbindelserInfo
- Publication number
- NO20043354L NO20043354L NO20043354A NO20043354A NO20043354L NO 20043354 L NO20043354 L NO 20043354L NO 20043354 A NO20043354 A NO 20043354A NO 20043354 A NO20043354 A NO 20043354A NO 20043354 L NO20043354 L NO 20043354L
- Authority
- NO
- Norway
- Prior art keywords
- acridone
- therapeutic
- acridine compounds
- acridine
- compounds
- Prior art date
Links
- GDALETGZDYOOGB-UHFFFAOYSA-N Acridone Natural products C1=C(O)C=C2N(C)C3=CC=CC=C3C(=O)C2=C1O GDALETGZDYOOGB-UHFFFAOYSA-N 0.000 title 1
- 150000001251 acridines Chemical class 0.000 title 1
- FZEYVTFCMJSGMP-UHFFFAOYSA-N acridone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3NC2=C1 FZEYVTFCMJSGMP-UHFFFAOYSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
- C07D219/10—Nitrogen atoms attached in position 9
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34789902P | 2002-01-15 | 2002-01-15 | |
| PCT/GB2003/000102 WO2003059885A1 (en) | 2002-01-15 | 2003-01-14 | Therapeutic acridone and acridine compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20043354L true NO20043354L (no) | 2004-10-01 |
Family
ID=23365764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20043354A NO20043354L (no) | 2002-01-15 | 2004-08-12 | Terapeutiske akridon- og akridinforbindelser |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7205311B2 (no) |
| EP (1) | EP1474397A1 (no) |
| JP (1) | JP2005519065A (no) |
| KR (1) | KR20040075934A (no) |
| CN (1) | CN1701063A (no) |
| AU (1) | AU2003201042A1 (no) |
| BR (1) | BR0306915A (no) |
| CA (1) | CA2473170A1 (no) |
| EA (1) | EA200400896A1 (no) |
| MX (1) | MXPA04006834A (no) |
| NO (1) | NO20043354L (no) |
| PL (1) | PL370449A1 (no) |
| WO (1) | WO2003059885A1 (no) |
| ZA (1) | ZA200405774B (no) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1363888A2 (en) * | 2000-07-07 | 2003-11-26 | Cancer Research Technology Limited | Therapeutic acridone and acridine compounds |
| CN100386624C (zh) * | 2005-01-27 | 2008-05-07 | 中国科学院大连化学物理研究所 | 一种荧光试剂的制备方法 |
| DE102005009909A1 (de) * | 2005-03-01 | 2006-09-07 | Heinrich-Heine-Universität Düsseldorf | Verbindungen geeignet zur Beseitigung fehlgefalteter Proteine |
| GB0505045D0 (en) * | 2005-03-11 | 2005-04-20 | Antisoma Plc | Cancer treatment |
| US20080119492A1 (en) * | 2005-07-29 | 2008-05-22 | Jean-Marie Lehn | Compositions and methods for treating cancer and other diseases characterized by abnormal cell proliferation |
| US8024762B2 (en) | 2006-06-13 | 2011-09-20 | Time Warner Cable Inc. | Methods and apparatus for providing virtual content over a network |
| GB0623492D0 (en) * | 2006-11-24 | 2007-01-03 | Univ London Pharmacy | Therapeutic G-quadruplex ligands |
| RU2363466C2 (ru) * | 2007-03-29 | 2009-08-10 | АО Ефаг | Способ и набор для лечения и профилактики злокачественных опухолей женской репродуктивной системы с применением 9-оксоакридин-10-уксусной кислоты, и/или ее соли, и/или ее сложного эфира |
| EP2152258B1 (en) * | 2007-05-10 | 2016-05-04 | Avalon Pharmaceuticals | Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof |
| EP2430015B1 (en) * | 2009-05-12 | 2015-06-17 | Merck Sharp & Dohme Corp. | Fused tricyclic compounds useful for the treatment of viral diseases |
| BRPI1105924A2 (pt) * | 2011-12-19 | 2013-11-12 | Ct Brasileiro De Pesquisas Fisicas Cbpf | Composto molecular para destruição seletiva de células de tumores sólidos |
| CN103923007B (zh) * | 2014-01-03 | 2016-07-06 | 大连理工大学 | 一类吖啶类化合物及其应用 |
| CN104326979B (zh) * | 2014-09-30 | 2015-12-30 | 广西中医药大学 | 2-甲基-9-吖啶(对甲氧基苯甲酰胺基)硫脲及其制备方法和用途 |
| CN107068881B (zh) * | 2016-04-25 | 2019-12-03 | 中节能万润股份有限公司 | 一种含有吖啶酮类化合物的有机电致发光器件及其应用 |
| CN115557890B (zh) * | 2022-09-01 | 2024-06-25 | 宁波大学 | 一种多取代吖啶酮烷基衍生物及其制备方法和用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE488890C (de) * | 1924-09-12 | 1930-01-23 | I G Farbenindustrie Akt Ges | Verfahren zur Darstellung von Aminoalkylaminosubstitutionsprodukten der Acridinreihe |
| EP1363888A2 (en) | 2000-07-07 | 2003-11-26 | Cancer Research Technology Limited | Therapeutic acridone and acridine compounds |
-
2003
- 2003-01-14 MX MXPA04006834A patent/MXPA04006834A/es active IP Right Grant
- 2003-01-14 JP JP2003559989A patent/JP2005519065A/ja not_active Withdrawn
- 2003-01-14 CN CNA038060639A patent/CN1701063A/zh active Pending
- 2003-01-14 BR BR0306915-0A patent/BR0306915A/pt not_active Application Discontinuation
- 2003-01-14 US US10/501,474 patent/US7205311B2/en not_active Expired - Fee Related
- 2003-01-14 EP EP03729511A patent/EP1474397A1/en not_active Withdrawn
- 2003-01-14 KR KR10-2004-7010933A patent/KR20040075934A/ko not_active Ceased
- 2003-01-14 EA EA200400896A patent/EA200400896A1/ru unknown
- 2003-01-14 ZA ZA200405774A patent/ZA200405774B/en unknown
- 2003-01-14 CA CA002473170A patent/CA2473170A1/en not_active Abandoned
- 2003-01-14 PL PL03370449A patent/PL370449A1/xx not_active Application Discontinuation
- 2003-01-14 AU AU2003201042A patent/AU2003201042A1/en not_active Abandoned
- 2003-01-14 WO PCT/GB2003/000102 patent/WO2003059885A1/en not_active Ceased
-
2004
- 2004-08-12 NO NO20043354A patent/NO20043354L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR0306915A (pt) | 2004-11-09 |
| KR20040075934A (ko) | 2004-08-30 |
| US7205311B2 (en) | 2007-04-17 |
| CA2473170A1 (en) | 2003-07-24 |
| EP1474397A1 (en) | 2004-11-10 |
| ZA200405774B (en) | 2005-11-04 |
| CN1701063A (zh) | 2005-11-23 |
| MXPA04006834A (es) | 2004-12-06 |
| US20050070568A1 (en) | 2005-03-31 |
| JP2005519065A (ja) | 2005-06-30 |
| EA200400896A1 (ru) | 2004-12-30 |
| AU2003201042A1 (en) | 2003-07-30 |
| WO2003059885A1 (en) | 2003-07-24 |
| PL370449A1 (en) | 2005-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60237997D1 (de) | Sicherheitsanordnung | |
| DE60333537D1 (de) | Herzschrittmacher | |
| DK1575618T3 (da) | Dispergerbare farmaceutiske kombinationer | |
| DE60209598D1 (de) | Sicherheitssack | |
| DE60301954D1 (de) | Implantierbare einrichtung | |
| EP1412378A4 (en) | APTAMERS AND ANTIAPTAMERS | |
| DE60319951D1 (de) | Aminocyclische substituierte pyrrolopyrimidinderivate und pyrrolopyridinderivate | |
| NO20043354L (no) | Terapeutiske akridon- og akridinforbindelser | |
| FI20012483L (fi) | MOSFETn avulla toteutettu polariteettisuoja | |
| NO20050689L (no) | Terapeutisk anvendelse | |
| DK1480970T3 (da) | Quinolinderivater | |
| ITBO20020206A0 (it) | Vasca idromassaggio | |
| DE50300456D1 (de) | Drehsperre | |
| DE60208612D1 (de) | Herzschrittmacher | |
| DE10393889D2 (de) | Medikament-Dosimeter-Kombipackung | |
| DE50209548D1 (de) | Substituierte 1-aryl-but-3-enylamin- und 1-aryl-but-2-enylaminverbindungen | |
| DE60229385D1 (de) | Herzschrittmacher | |
| NO20043433L (no) | Fremgangsmate | |
| ATA4762002A (de) | Uv-kaschierter sicherheitsfaden | |
| NO20052727D0 (no) | Tetrahydrokinolinderivater | |
| ITMO20020090A1 (it) | Dispositivo di sicurezza | |
| ITMO20020158A0 (it) | Dispositivo di sicurezza | |
| ES1050993Y (es) | Roblon de seguridad | |
| FI20020351A7 (fi) | Vauhdinantolaite | |
| IS7870A (is) | Tetrahýdrókínólín afleiður |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |